2022
DOI: 10.1016/j.jedc.2022.104308
|View full text |Cite
|
Sign up to set email alerts
|

Integrated epi-econ assessment of vaccination

Abstract: Using an integrated epi-econ model, we compute the value of vaccines for Covid-19, both under a planner’s solution and in competitive equilibrium. The specific model, developed in Boppart, Harmenberg, Hassler, Krusell, and Olsson (2021), factors in not just value-of-life aspects along with standard economic variables but also the value of leisure activities that rely on a social component. We find that the societal value of vaccination is large; we estimate that, translated into monetary terms, the value of va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…The pulling of labour out of agriculture into industrial and service sector jobs has been an important way to reduce poverty and the rural‐urban income gap in many countries (Boppart et al., 2023). However, that contribution has been relatively slow in Fiji.…”
Section: Fijiʼs Structural Transformation and Evolving Comparative Ad...mentioning
confidence: 99%
“…The pulling of labour out of agriculture into industrial and service sector jobs has been an important way to reduce poverty and the rural‐urban income gap in many countries (Boppart et al., 2023). However, that contribution has been relatively slow in Fiji.…”
Section: Fijiʼs Structural Transformation and Evolving Comparative Ad...mentioning
confidence: 99%
“…One of the differences is the modeling of testing capacity and associated quarantines. Boppart et al (2022) builds on Boppart et al (2020) to study the value of vaccination and shows that it is high and increasing with age. outside the house, the agent may catch a disease, which may be Covid-19 or a common cold.…”
Section: Modelmentioning
confidence: 99%
“…The need to estimate benefits was not as pressing for the first round of SARS-CoV-2 vaccines, because there was little doubt that their benefits exceeded their costs [6] , [26] , [32] , [36] , [39] . However, for subsequent rounds of booster vaccines the case is less clear.…”
Section: Introductionmentioning
confidence: 99%